Covid-19 Impact on Pediatric Vaccines Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Pediatric Vaccines Industry

1.7 COVID-19 Impact: Pediatric Vaccines Market Trends

2 Global Pediatric Vaccines Quarterly Market Size Analysis

2.1 Pediatric Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Pediatric Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Pediatric Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Pediatric Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Pediatric Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Pediatric Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Pediatric Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Pediatric Vaccines Market

3.5 Key Manufacturers Pediatric Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Pediatric Vaccines Segments, By Type

4.1 Introduction

1.4.1 Diphtheria

1.4.2 Influenza

1.4.3 Hepatitis

1.4.4 Pneumococcal Diseases

1.4.5 Meningococcal Diseases

1.4.6 Others

4.2 By Type, Global Pediatric Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Pediatric Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Pediatric Vaccines Price, 2020-2021

5 Impact of Covid-19 on Pediatric Vaccines Segments, By Application

5.1 Overview

5.5.1 Newborn

5.5.2 Infant

5.5.3 Child

5.5.4 Dolescent

5.2 By Application, Global Pediatric Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Pediatric Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Pediatric Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Business Overview

7.1.2 GlaxoSmithKline Pediatric Vaccines Quarterly Production and Revenue, 2020

7.1.3 GlaxoSmithKline Pediatric Vaccines Product Introduction

7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.2 Merck

7.2.1 Merck Business Overview

7.2.2 Merck Pediatric Vaccines Quarterly Production and Revenue, 2020

7.2.3 Merck Pediatric Vaccines Product Introduction

7.2.4 Merck Response to COVID-19 and Related Developments

7.3 Pfizer

7.3.1 Pfizer Business Overview

7.3.2 Pfizer Pediatric Vaccines Quarterly Production and Revenue, 2020

7.3.3 Pfizer Pediatric Vaccines Product Introduction

7.3.4 Pfizer Response to COVID-19 and Related Developments

7.4 Sanofi

7.4.1 Sanofi Business Overview

7.4.2 Sanofi Pediatric Vaccines Quarterly Production and Revenue, 2020

7.4.3 Sanofi Pediatric Vaccines Product Introduction

7.4.4 Sanofi Response to COVID-19 and Related Developments

7.5 AstraZeneca

7.5.1 AstraZeneca Business Overview

7.5.2 AstraZeneca Pediatric Vaccines Quarterly Production and Revenue, 2020

7.5.3 AstraZeneca Pediatric Vaccines Product Introduction

7.5.4 AstraZeneca Response to COVID-19 and Related Developments

7.6 Novartis

7.6.1 Novartis Business Overview

7.6.2 Novartis Pediatric Vaccines Quarterly Production and Revenue, 2020

7.6.3 Novartis Pediatric Vaccines Product Introduction

7.6.4 Novartis Response to COVID-19 and Related Developments

7.7 Takeda Pharmaceutical

7.7.1 Takeda Pharmaceutical Business Overview

7.7.2 Takeda Pharmaceutical Pediatric Vaccines Quarterly Production and Revenue, 2020

7.7.3 Takeda Pharmaceutical Pediatric Vaccines Product Introduction

7.7.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments

7.8 Bavarian Nordic

7.8.1 Bavarian Nordic Business Overview

7.8.2 Bavarian Nordic Pediatric Vaccines Quarterly Production and Revenue, 2020

7.8.3 Bavarian Nordic Pediatric Vaccines Product Introduction

7.8.4 Bavarian Nordic Response to COVID-19 and Related Developments

7.9 Baxter

7.9.1 Baxter Business Overview

7.9.2 Baxter Pediatric Vaccines Quarterly Production and Revenue, 2020

7.9.3 Baxter Pediatric Vaccines Product Introduction

7.9.4 Baxter Response to COVID-19 and Related Developments

7.10 LG Life Sciences

7.10.1 LG Life Sciences Business Overview

7.10.2 LG Life Sciences Pediatric Vaccines Quarterly Production and Revenue, 2020

7.10.3 LG Life Sciences Pediatric Vaccines Product Introduction

7.10.4 LG Life Sciences Response to COVID-19 and Related Developments

7.11 Lupin

7.11.1 Lupin Business Overview

7.11.2 Lupin Pediatric Vaccines Quarterly Production and Revenue, 2020

7.11.3 Lupin Pediatric Vaccines Product Introduction

7.11.4 Lupin Response to COVID-19 and Related Developments

7.12 S K Chemicals

7.12.1 S K Chemicals Business Overview

7.12.2 S K Chemicals Pediatric Vaccines Quarterly Production and Revenue, 2020

7.12.3 S K Chemicals Pediatric Vaccines Product Introduction

7.12.4 S K Chemicals Response to COVID-19 and Related Developments

7.13 Mitsubishi Tanabe Pharma

7.13.1 Mitsubishi Tanabe Pharma Business Overview

7.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Quarterly Production and Revenue, 2020

7.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Introduction

7.13.4 Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

7.14 Janssen

7.14.1 Janssen Business Overview

7.14.2 Janssen Pediatric Vaccines Quarterly Production and Revenue, 2020

7.14.3 Janssen Pediatric Vaccines Product Introduction

7.14.4 Janssen Response to COVID-19 and Related Developments

7.15 Shenzhen Kangtai Biological Products

7.15.1 Shenzhen Kangtai Biological Products Business Overview

7.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Quarterly Production and Revenue, 2020

7.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Introduction

7.15.4 Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

7.16 Sinovac Biotech

7.16.1 Sinovac Biotech Business Overview

7.16.2 Sinovac Biotech Pediatric Vaccines Quarterly Production and Revenue, 2020

7.16.3 Sinovac Biotech Pediatric Vaccines Product Introduction

7.16.4 Sinovac Biotech Response to COVID-19 and Related Developments

7.17 Bharat Biotech

7.17.1 Bharat Biotech Business Overview

7.17.2 Bharat Biotech Pediatric Vaccines Quarterly Production and Revenue, 2020

7.17.3 Bharat Biotech Pediatric Vaccines Product Introduction

7.17.4 Bharat Biotech Response to COVID-19 and Related Developments

7.18 Crucell

7.18.1 Crucell Business Overview

7.18.2 Crucell Pediatric Vaccines Quarterly Production and Revenue, 2020

7.18.3 Crucell Pediatric Vaccines Product Introduction

7.18.4 Crucell Response to COVID-19 and Related Developments

7.19 Dynavax

7.19.1 Dynavax Business Overview

7.19.2 Dynavax Pediatric Vaccines Quarterly Production and Revenue, 2020

7.19.3 Dynavax Pediatric Vaccines Product Introduction

7.19.4 Dynavax Response to COVID-19 and Related Developments

7.20 Serum Institute of India

7.20.1 Serum Institute of India Business Overview

7.20.2 Serum Institute of India Pediatric Vaccines Quarterly Production and Revenue, 2020

7.20.3 Serum Institute of India Pediatric Vaccines Product Introduction

7.20.4 Serum Institute of India Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Pediatric Vaccines Supply Chain Analysis

8.1.1 Pediatric Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Pediatric Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Pediatric Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Pediatric Vaccines Distribution Channels

8.2.3 Pediatric Vaccines Distributors

8.3 Pediatric Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Licenses Type

USD 3,250 Single License

USD 6,500 Enterprise License

BUY NOW Add to Cart

Why QYR

Fastest report delivery service

More than 10 years of vast experience

Operational for 24 * 7 & 365 days

In-depth and comprehensive analysis

Excellent after sales support

Owns large database

Need Help ?

Email Us FAQ

Covid 19 Impact on Pediatric Vaccines market

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Pediatric Vaccines Assessment

Table 9. COVID-19 Impact: Pediatric Vaccines Market Trends

Table 10. COVID-19 Impact Global Pediatric Vaccines Market Size

Table 11. Global Pediatric Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Pediatric Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Pediatric Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Pediatric Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Pediatric Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Pediatric Vaccines Market Growth Drivers

Table 17. Global Pediatric Vaccines Market Restraints

Table 18. Global Pediatric Vaccines Market Opportunities

Table 19. Global Pediatric Vaccines Market Challenges

Table 20. Key Manufacturers Pediatric Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Pediatric Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Pediatric Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Pediatric Vaccines Manufacturing Plants

Table 24. Key Manufacturers Pediatric Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Pediatric Vaccines Market

Table 26. Key Manufacturers Pediatric Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pediatric Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Pediatric Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Pediatric Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Pediatric Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Pediatric Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Pediatric Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Pediatric Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Pediatric Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Pediatric Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Pediatric Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Pediatric Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Pediatric Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Pediatric Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Pediatric Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Pediatric Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. GlaxoSmithKline Business Overview

Table 58. GlaxoSmithKline Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. GlaxoSmithKline Pediatric Vaccines Product

Table 60. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 61. Merck Business Overview

Table 62. Merck Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Merck Pediatric Vaccines Product

Table 64. Merck Response to COVID-19 and Related Developments

Table 65. Pfizer Business Overview

Table 66. Pfizer Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Pfizer Pediatric Vaccines Product

Table 68. Pfizer Response to COVID-19 and Related Developments

Table 69. Sanofi Business Overview

Table 70. Sanofi Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Sanofi Pediatric Vaccines Product

Table 72. Sanofi Response to COVID-19 and Related Developments

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. AstraZeneca Pediatric Vaccines Product

Table 76. AstraZeneca Response to COVID-19 and Related Developments

Table 77. Novartis Business Overview

Table 78. Novartis Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Novartis Pediatric Vaccines Product

Table 80. Novartis Response to COVID-19 and Related Developments

Table 81. Takeda Pharmaceutical Business Overview

Table 82. Takeda Pharmaceutical Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Takeda Pharmaceutical Pediatric Vaccines Product

Table 84. Takeda Pharmaceutical Response to COVID-19 and Related Developments

Table 85. Bavarian Nordic Business Overview

Table 86. Bavarian Nordic Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Bavarian Nordic Pediatric Vaccines Product

Table 88. Bavarian Nordic Response to COVID-19 and Related Developments

Table 89. Baxter Business Overview

Table 90. Baxter Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Baxter Pediatric Vaccines Product

Table 92. Baxter Response to COVID-19 and Related Developments

Table 93. LG Life Sciences Business Overview

Table 94. LG Life Sciences Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. LG Life Sciences Pediatric Vaccines Product

Table 96. LG Life Sciences Response to COVID-19 and Related Developments

Table 97. Lupin Business Overview

Table 98. Lupin Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Lupin Pediatric Vaccines Product

Table 100. Lupin Response to COVID-19 and Related Developments

Table 101. S K Chemicals Business Overview

Table 102. S K Chemicals Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. S K Chemicals Pediatric Vaccines Product

Table 104. S K Chemicals Response to COVID-19 and Related Developments

Table 105. Mitsubishi Tanabe Pharma Business Overview

Table 106. Mitsubishi Tanabe Pharma Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Mitsubishi Tanabe Pharma Pediatric Vaccines Product

Table 108. Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

Table 109. Janssen Business Overview

Table 110. Janssen Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Janssen Pediatric Vaccines Product

Table 112. Janssen Response to COVID-19 and Related Developments

Table 113. Shenzhen Kangtai Biological Products Business Overview

Table 114. Shenzhen Kangtai Biological Products Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Shenzhen Kangtai Biological Products Pediatric Vaccines Product

Table 116. Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

Table 117. Sinovac Biotech Business Overview

Table 118. Sinovac Biotech Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 119. Sinovac Biotech Pediatric Vaccines Product

Table 120. Sinovac Biotech Response to COVID-19 and Related Developments

Table 121. Bharat Biotech Business Overview

Table 122. Bharat Biotech Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 123. Bharat Biotech Pediatric Vaccines Product

Table 124. Bharat Biotech Response to COVID-19 and Related Developments

Table 125. Crucell Business Overview

Table 126. Crucell Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 127. Crucell Pediatric Vaccines Product

Table 128. Crucell Response to COVID-19 and Related Developments

Table 129. Dynavax Business Overview

Table 130. Dynavax Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 131. Dynavax Pediatric Vaccines Product

Table 132. Dynavax Response to COVID-19 and Related Developments

Table 133. Serum Institute of India Business Overview

Table 134. Serum Institute of India Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 135. Serum Institute of India Pediatric Vaccines Product

Table 136. Serum Institute of India Response to COVID-19 and Related Developments

Table 137. Pediatric Vaccines Distributors List

Table 138. Pediatric Vaccines Customers List

Table 139. Covid-19 Impact on Pediatric Vaccines Customers

List of Figures

Figure 1. Pediatric Vaccines Product Picture

Figure 2. Pediatric Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Pediatric Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Pediatric Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Pediatric Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Pediatric Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Pediatric Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Pediatric Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Pediatric Vaccines Market Size Market Share, 2019-2021